Clinical Trials Browser

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Phase 3 Recruiting

99 enrolled

Plasma cell

Multiple Myeloma

NCT06056752 2023-10-24

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1 Recruiting

10 enrolled

Lymphoid

Burkitt Lymphoma

NCT05963347 2023-09-01

Go-CHOP as the Frontline Therapy for PTCL

Phase 2 Recruiting

45 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03166397 2023-01-26

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Phase 2 Recruiting

30 enrolled

Dermatologic

Melanoma

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Phase 1 Recruiting

10 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

Clinical Trials

PTCy and ATG for MSD and MUD Transplants

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Go-CHOP as the Frontline Therapy for PTCL

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies